How will AI revolutionise oncology?
3 min
Available until 04/02/2027
With 58,000 cases annually, breast cancer remains the leading cause of cancer death for women. However, the AI-powered software RlapsRisk—developed by the Gustave Roussy Institute and a Franco-American startup—offers new hope by accurately predicting relapse risks through advanced medical image analysis.
You may also like
The most viewed videos on ARTE
NotInitialized